trial · primary record
LB-208
Solid Tumor Malignancies
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 57 |
| Primary completion | 2026-12 |
| Primary endpoint | Incidence of Treatment related Adverse events (Safety and Tolerability) |
| Registry ID | NCT07914348 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:26.811Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07914348
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.